Telemetry Investments, L.L.C. Aclaris Therapeutics, Inc. Transaction History

Telemetry Investments, L.L.C.

$63.3 Million
Q4 2022

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$10.16 - $17.08 $80,954 - $136,093	-7,968 Reduced 41.91%	11,043 $154,000
Q1 2022 May 16, 2022	SELL	$9.74 - $17.92 $107,032 - $196,922	-10,989 Reduced 36.63%	19,011 $328,000
Q4 2021 Feb 14, 2022	SELL	$12.27 - $18.49 $18,405 - $27,734	-1,500 Reduced 4.76%	30,000 $436,000
Q3 2021 Nov 15, 2021	SELL	$13.38 - $18.8 $33,690 - $47,338	-2,518 Reduced 7.4%	31,500 $567,000
Q2 2021 Aug 16, 2021	BUY	$17.08 - $29.6 $410,227 - $710,932	24,018 Added 240.18%	34,018 $597,000
Q1 2021 May 17, 2021	SELL	$5.86 - $27.73 $215,648 - $1.02 Million	-36,800 Reduced 78.63%	10,000 $252,000
Q4 2020 Feb 16, 2021	SELL	$2.65 - $7.61 $584,764 - $1.68 Million	-220,666 Reduced 82.5%	46,800 $303,000
Q3 2020 Nov 16, 2020	SELL	$1.5 - $2.71 $309,673 - $559,476	-206,449 Reduced 43.56%	267,466 $687,000
Q2 2020 Aug 14, 2020	SELL	$1.04 - $1.73 $28,168 - $46,857	-27,085 Reduced 5.41%	473,915 $768,000
Q1 2020 May 15, 2020	BUY	$0.75 - $2.18 $45,000 - $130,800	60,000 Added 13.61%	501,000 $521,000
Q4 2019 Feb 14, 2020	BUY	$1.02 - $1.97 $230,935 - $446,021	226,407 Added 105.51%	441,000 $833,000
Q3 2019 Nov 14, 2019	BUY	$0.79 - $2.47 $19,799 - $61,905	25,063 Added 13.22%	214,593 $232,000
Q2 2019 Aug 14, 2019	BUY	$2.13 - $7.06 $86,320 - $286,113	40,526 Added 27.2%	189,530 $415,000
Q1 2019 May 15, 2019	BUY	$5.63 - $7.84 $284,337 - $395,951	50,504 Added 51.27%	149,004 $893,000
Q4 2018 Feb 14, 2019	BUY	$6.3 - $15.4 $355,950 - $870,100	56,500 Added 134.52%	98,500 $728,000
Q3 2018 Nov 14, 2018	BUY	$14.38 - $20.89 $86,280 - $125,340	6,000 Added 16.67%	42,000 $610,000
Q2 2018 Aug 14, 2018	SELL	$16.46 - $20.33 $329,200 - $406,599	-20,000 Reduced 35.71%	36,000 $719,000
Q1 2018 May 15, 2018	BUY	$17.08 - $25.64 $956,479 - $1.44 Million	56,000 New	56,000 $981,000

Others Institutions Holding ACRS

# of Institutions

Shares Held

50.7M

Call Options Held

30.6K

Put Options Held

Bml Capital Management, LLC Zionsville, IN

14.3M
Shares

$41.6 Million
9.64% of portfolio
Vanguard Group Inc Valley Forge, PA

4.69M
Shares

$13.7 Million
0.0% of portfolio
D. E. Shaw & Co., Inc. New York, NY

3.37M
Shares

$9.85 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.01M
Shares

$8.78 Million
0.0% of portfolio
Rock Springs Capital Management LP Baltimore, MD

2.75M
Shares

$8.04 Million
0.11% of portfolio

View Full List

About Aclaris Therapeutics, Inc.

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $195M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

More about ACRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Telemetry Investments, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Telemetry Investments, L.L.C. with notifications on news.

Account